Steady‐state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug‐resistant tuberculosis
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13975
Abstract: Despite terizidone being part of the second‐line recommended drugs for treatment of drug‐resistant tuberculosis (DR‐TB), information on its pharmacokinetics is scarce. The aim of this study was to describe the steady‐state population pharmacokinetics (PPK) of… read more here.
Keywords: metabolite cycloserine; state population; drug resistant; population pharmacokinetics ... See more keywords